FLASH assembly of TALENs for high-throughput genome editing

Transcription activator–like effector nucleases (TALENs) enable genetic modification at specific sites in a genome. Reyon et al . present a method for high-throughput generation of TALENs, facilitating large-scale genome engineering. Engineered transcription activator–like effector nucleases (TALENs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2012-05, Vol.30 (5), p.460-465
Hauptverfasser: Reyon, Deepak, Tsai, Shengdar Q, Khayter, Cyd, Foden, Jennifer A, Sander, Jeffry D, Joung, J Keith
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Transcription activator–like effector nucleases (TALENs) enable genetic modification at specific sites in a genome. Reyon et al . present a method for high-throughput generation of TALENs, facilitating large-scale genome engineering. Engineered transcription activator–like effector nucleases (TALENs) have shown promise as facile and broadly applicable genome editing tools. However, no publicly available high-throughput method for constructing TALENs has been published, and large-scale assessments of the success rate and targeting range of the technology remain lacking. Here we describe the fast ligation-based automatable solid-phase high-throughput (FLASH) system, a rapid and cost-effective method for large-scale assembly of TALENs. We tested 48 FLASH-assembled TALEN pairs in a human cell–based EGFP reporter system and found that all 48 possessed efficient gene-modification activities. We also used FLASH to assemble TALENs for 96 endogenous human genes implicated in cancer and/or epigenetic regulation and found that 84 pairs were able to efficiently introduce targeted alterations. Our results establish the robustness of TALEN technology and demonstrate that FLASH facilitates high-throughput genome editing at a scale not currently possible with other genome modification technologies.
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt.2170